AVITA Medical, Inc.

NasdaqCM:RCEL 株式レポート

時価総額:US$349.9m

AVITA Medical マネジメント

マネジメント 基準チェック /24

AVITA Medicalの CEO はJim Corbettで、 Sep2022年に任命され、 の在任期間は 2.17年です。 の年間総報酬は$ 2.07Mで、 30.2%給与と69.8%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.033%を直接所有しており、その価値は$ 115.92K 。経営陣と取締役会の平均在任期間はそれぞれ1.8年と6.1年です。

主要情報

Jim Corbett

最高経営責任者

US$2.1m

報酬総額

CEO給与比率30.2%
CEO在任期間2.2yrs
CEOの所有権0.03%
経営陣の平均在職期間1.8yrs
取締役会の平均在任期間6.1yrs

経営陣の近況

Recent updates

AVITA Medical, Inc.'s (NASDAQ:RCEL) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Oct 04
AVITA Medical, Inc.'s (NASDAQ:RCEL) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

AVITA Medical, Inc. (NASDAQ:RCEL) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Aug 11
AVITA Medical, Inc. (NASDAQ:RCEL) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

AVITA Medical, Inc.'s (NASDAQ:RCEL) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Jul 18
AVITA Medical, Inc.'s (NASDAQ:RCEL) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Is AVITA Medical (NASDAQ:RCEL) A Risky Investment?

Jun 18
Is AVITA Medical (NASDAQ:RCEL) A Risky Investment?

Little Excitement Around AVITA Medical, Inc.'s (NASDAQ:RCEL) Revenues As Shares Take 39% Pounding

Apr 12
Little Excitement Around AVITA Medical, Inc.'s (NASDAQ:RCEL) Revenues As Shares Take 39% Pounding

AVITA Medical, Inc.'s (NASDAQ:RCEL) Price Is Right But Growth Is Lacking After Shares Rocket 39%

Feb 02
AVITA Medical, Inc.'s (NASDAQ:RCEL) Price Is Right But Growth Is Lacking After Shares Rocket 39%

The Market Doesn't Like What It Sees From AVITA Medical, Inc.'s (NASDAQ:RCEL) Revenues Yet As Shares Tumble 32%

Oct 20
The Market Doesn't Like What It Sees From AVITA Medical, Inc.'s (NASDAQ:RCEL) Revenues Yet As Shares Tumble 32%

Avita Medical appoints James Corbett as CEO

Sep 29

AVITA Medical says trial evaluating its RECELL system to treat vitiligo met main goal

Sep 12

Avita's burn therapy Recell gets insurance coverage in Japan following approval

Sep 01

AVITA Medical GAAP EPS of -$0.25 beats by $0.15, revenue of $8.34M beats by $1.18M

Aug 11

AVITA Medical Is Interesting, But Not Just Yet

Dec 21

AVITA Medical reports preliminary Q2 revenue in-line with consensus

Jan 12

AVITA: COVID-19's Impact

Nov 17

CEO報酬分析

AVITA Medical の収益と比較して、Jim Corbett の報酬はどのように変化したか?
日付総報酬給与会社業績
Sep 30 2024n/an/a

-US$57m

Jun 30 2024n/an/a

-US$50m

Mar 31 2024n/an/a

-US$45m

Dec 31 2023US$2mUS$625k

-US$35m

Sep 30 2023n/an/a

-US$34m

Jun 30 2023n/an/a

-US$31m

Mar 31 2023n/an/a

-US$26m

Dec 31 2022US$2mUS$157k

-US$27m

Sep 30 2022n/an/a

-US$30m

Jun 30 2022n/an/a

-US$30m

Mar 31 2022n/an/a

-US$29m

Dec 31 2021US$256kn/a

-US$25m

報酬と市場: Jimの 総報酬 ($USD 2.07M ) は、 US市場 ($USD 2.14M ) の同様の規模の企業の平均とほぼ同じです。

報酬と収益: Jimの報酬は増加しましたが、会社は利益を上げていません。


CEO(最高経営責任者

Jim Corbett (66 yo)

2.2yrs

在職期間

US$2,068,675

報酬

Mr. James M. Corbett, also known as Jim, served as Chief Executive Officer of CathWorks Ltd. since October 27, 2017 until 2021. He serves as Director of CathWorks Ltd.until 2021. He served as an Independe...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
James Corbett
CEO, President & Executive Director2.2yrsUS$2.07m0.033%
$ 115.9k
David O'Toole
Chief Financial Officer1.4yrsUS$2.18mデータなし
David Fencil
Senior Vice President of Global Operations1.8yrsデータなしデータなし
Katie Bush
Senior Vice President of Scientific & Medical Affairsless than a yearデータなしデータなし
Jessica Ekeberg
Investor Relations Executiveno dataデータなしデータなし
Nicole Kelsey
Chief Legal & Compliance Officer and Corporate Secretaryless than a yearデータなしデータなし
Debbie Garner
Senior Vice President of Global Marketing & Strategy6.3yrsデータなしデータなし
Rob Hall
Senior Vice President of Human Resources1.8yrsデータなしデータなし
Niraj Doshi
Senior Vice President of Product Development & Program Management1.8yrsデータなしデータなし
Ron Lagerquist
Senior Vice President of Quality Assurance & Regulatory Affairs1.8yrsデータなしデータなし
Robin VanDenburgh
Senior Vice President of U.S. Commercial Salesless than a yearデータなしデータなし

1.8yrs

平均在職期間

経験豊富な経営陣: RCELの経営陣は 経験豊富 とはみなされません ( 1.8年の平均在職年数)。これは新しいチームを示唆しています。


取締役

名称ポジション在職期間報酬所有権
James Corbett
CEO, President & Executive Director3.3yrsUS$2.07m0.033%
$ 115.9k
Jan Reed
Independent Non-Executive Director3.3yrsUS$211.12k0.11%
$ 385.5k
Jeremy Curnock-Cook
Independent Non-Executive Director12.1yrsUS$199.87k0.079%
$ 275.0k
Fiona Wood
Founder and Member of Clinical Advisory Board8.8yrsUS$29.80kデータなし
Louis Panaccio
Independent Non-Executive Chairman10.3yrsUS$234.69k0.16%
$ 576.0k
Robert McNamara
Independent Non-Executive Director1.6yrsUS$369.11k0.075%
$ 261.9k
Cary Vance
Independent Non-Executive Director1.6yrsUS$364.94k0.037%
$ 128.5k
Suzanne Crowe
Independent Non-Executive Director8.8yrsUS$195.28k0.10%
$ 363.2k

6.1yrs

平均在職期間

67yo

平均年齢

経験豊富なボード: RCELの 取締役会経験豊富 であると考えられます ( 6.1年の平均在任期間)。